An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system
Innovative therapeutics like biologicals that modulate the immune system are on the rise. However, their immune-modulating characteristics can also lead sometimes to the induction of adverse effects, by triggering unintended immune reactions. Due to the complexity and target-specificity of such ther...
Saved in:
| Main Authors: | Vanessa Neuhaus, Laure-Alix Clerbaux, Katherina Sewald |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Immunotoxicology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/1547691X.2024.2354213 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using irAOP for non-clinical safety evaluation of biotechnology-derived pharmaceuticals and ATMPs: a paradigm shift into a systematic and holistic framework
by: Armin Braun, et al.
Published: (2024-12-01) -
Analyzing IL-2-induced vascular leakage with an irAOP as tool
by: Patricia Gogesch, et al.
Published: (2024-12-01) -
Revival of recombinant IL-2 therapy – approaches from the past until today
by: Luise A. Roser, et al.
Published: (2024-12-01) -
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies
by: Alexander Mazein, et al.
Published: (2025-08-01) -
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
by: Alexander Mazein, et al.
Published: (2024-12-01)